BioCentury
ARTICLE | Company News

Meda's Dymista approved for allergic rhinitis

January 25, 2013 1:57 AM UTC

Meda AB (SSE:MEDAA) said its Dymista azelastine/fluticasone was approved under the EU's decentralized procedure to treat seasonal and perennial allergic rhinitis. Germany acted as the reference member...